Marketing-authorisation holder · Canada
Vetoquinol N A Inc
260 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
260 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 260
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACEVET 25 INJECTABLE25 mg / ml · Solution | Acepromazine | Canada | Marketed | 1981 |
| ANTI GAZ EMULSION FLAVOURED2 mg / ml · Emulsion | Docusate | Canada | Marketed | 1965 |
| AURIZON10 mg / ml + 0.9 mg / ml + 3 mg / ml · Suspension | Clotrimazole, Dexamethasone, Marbofloxacin | Canada | Marketed | 2010 |
| BIOESTROVET250 mcg / ml · Solution | Cloprostenol | Canada | Marketed | 2017 |
| BIOESTROVET SWINE87.5 mcg / ml · Solution | Cloprostenol | Canada | Marketed | 2024 |
| BUTEQUINE1 g / 3 ml · Paste | Phenylbutazone | Canada | Not marketed | 1982 |
| CALF-LYTE II0.012 g / 76 g + 41.734 g / 76 g + 6.756 g / 76 g + 1.940 g / 76 g + 0.349 g / 76 g + 13.125 g / 76 g + 3.507 g / 76 g + 0.600 g / 76 g · Powder For Solution | D-pantothenic acid, Dextrose, Glycine, Potassium chloride, Dibasic, Sodium acetate, Sodium chloride, Monobasic | Canada | Marketed | 2000 |
| CALF-LYTE II HE0.012 g / 185 g + 149.04 g / 185 g + 6.756 g / 185 g + 1.940 g / 185 g + 0.349 g / 185 g + 13.127 g / 185 g + 3.507 g / 185 g + 0.600 g / 185 g · Powder For Solution | D-pantothenic acid, Dextrose, Glycine, Potassium chloride, Dibasic, Sodium acetate, Sodium chloride | Canada | Marketed | 2000 |
| CEFASEPTIN 300 MG300 mg · Tablet (Chewable) | Cefalexin | Canada | Marketed | 2017 |
| CEFASEPTIN 75 MG75 mg · Tablet (Chewable) | Cefalexin | Canada | Authorised | |
| CEFASEPTIN 750 MG750 mg · Tablet (Chewable) | Cefalexin | Canada | Marketed | 2017 |
| CHLOR PALM 250 (CHLORAMPHENICOL PALMITATE ORAL SUSPENSION)50 mg / ml · Suspension | Chloramphenicol | Canada | Marketed | 1988 |
| CLAVASEPTIN 250 MG200 mg + 50 mg · Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2008 |
| CLAVASEPTIN 50 MG40 mg + 10 mg · Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2008 |
| CLAVASEPTIN 500 MG400 mg + 100 mg · Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2008 |
| CLAVASEPTIN 62.5MG50 mg + 12.5 mg · Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2013 |
| CLAVASEPTIN 750 MG600 mg + 150 mg · Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2023 |
| COTHIVET TOPICAL SPRAY89.5 % · Spray | Hydrocotyle | Canada | Not marketed | 1993 |
| DEXAFER-200200 mg / ml · Solution | Iron | Canada | Marketed | 2005 |
| DEXAMETHASONE 2 STERILE INJECTABLE SOLUTION2 mg / ml · Solution | Dexamethasone | Canada | Marketed | 1985 |
| DEXAMETHASONE 5 STERILE INJECTABLE SOLUTION5 mg / ml · Solution | Dexamethasone | Canada | Marketed | 1983 |
| DOLPAC 10559.0 mg + 50.0 mg + 144.0 mg · Tablet | Oxantel, Praziquantel, Pyrantel | Canada | Marketed | 2010 |
| DOLPAC 2111.8 mg + 10.0 mg + 28.8 mg · Tablet | Oxantel, Praziquantel, Pyrantel | Canada | Marketed | 2010 |
| DOLPAC 251397.5 mg + 125.0 mg + 360.0 mg · Tablet | Oxantel, Praziquantel, Pyrantel | Canada | Marketed | 2010 |
| EPIPHEN 30MG30 mg · Tablet | Phenobarbital | Canada | Marketed | 2014 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 260 | 47 | 213 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.